SEK5.60
1.75% today
Stockholm, Feb 28, 05:00 pm CET
ISIN
SE0002478776
Symbol
SEZI
Sector

Senzime Stock price

SEK5.70
-0.10 1.72% 1M
-2.19 27.76% 6M
+0.20 3.64% YTD
-0.80 12.31% 1Y
-12.15 68.07% 3Y
-10.08 63.88% 5Y
-0.57 9.13% 10Y
Stockholm, Closing price Thu, Feb 27 2025
-0.04 0.70%
ISIN
SE0002478776
Symbol
SEZI
Sector

Key metrics

Market capitalization SEK759.10m
Enterprise Value SEK680.83m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 11.64
P/S ratio (TTM) P/S ratio 12.98
P/B ratio (TTM) P/B ratio 2.19
Revenue growth (TTM) Revenue growth 63.55%
Revenue (TTM) Revenue SEK58.48m
EBIT (operating result TTM) EBIT SEK-133.46m
Free Cash Flow (TTM) Free Cash Flow SEK-108.30m
Cash position SEK100.94m
EPS (TTM) EPS SEK-0.97
P/E forward negative
P/S forward 6.33
EV/Sales forward 5.67
Show more

Is Senzime a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Financial data from Senzime

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
58 58
64% 64%
100%
- Direct Costs 40 40
42% 42%
68%
19 19
142% 142%
32%
- Selling and Administrative Expenses 111 111
6% 6%
189%
- Research and Development Expense 22 22
15% 15%
38%
-114 -114
2% 2%
-195%
- Depreciation and Amortization 19 19
10% 10%
33%
EBIT (Operating Income) EBIT -133 -133
0% 0%
-228%
Net Profit -119 -119
11% 11%
-203%

In millions SEK.

Don't miss a Thing! We will send you all news about Senzime directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. It manufactures products for automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patient's neuromuscular function perioperatively and in the intensive care medicine setting. The company also distributes bioreactor systems for the pharmaceutical industry. Senzime was founded by Thomas Ambjorn Carlsson in 1999 and is headquartered in Uppsala, Sweden.

Head office Sweden
CEO Philip Siberg
Founded 1999
Website www.senzime.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today